Atlas FDA

COBAS(R) CORE FT4 EIA

FDA 510(k) clearance K932607 · decided 1994-01-24

Clearance details

K-number
K932607
Device name
COBAS(R) CORE FT4 EIA
Applicant
Roche Diagnostic Systems, Inc.
Decision
Substantially Equivalent
Date received
1993-05-28
Decision date
1994-01-24
Days to decision
241 days
Clearance type
Traditional
Product code
CEC
Device class
2
Regulation number
862.1695
Medical specialty
Clinical Chemistry
Advisory committee
Clinical Chemistry
Location
Branchburg, NJ, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Roche Diagnostic Systems

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Access Free T4 (K240273)Beckman Coulter, Inc.2024-03-06
Elecsys FT4 IV (K220456)Roche Diagnostics2023-04-07
MAGLUMI 2000 FT4 (K182423)Shenzhen New Industries Biomedical Engineering Co., Ltd.2018-10-04
Elecsys FT4 III (K181233)Roche Diagnostics2018-09-18
Abbott Architect Free T4 (K173122)Abbott Laboratories2017-10-27
FREND™ Free T4 Test System (K152422)Nanoentek USA, Inc.2016-02-17
VIDAS FT4 (K132058)Biomerieux S.A.2015-06-08
DIMENSION VISTA FREE THYROXINE FLEX REAGENT CARTRIDGE, FT4, DIMENSION VISTA THYROID STIMULATING HORMONE FLEX REAGENT (K140859)Siemens Healthcare Diagnostics, Inc.2014-11-26
DIMENSION LOCI FREE THYROXINE FLEX REAGENT CARTRIDGE, FT4L, DIMENSION LOCI THYROID STIMULATING HORMONE FLEX REAGENT CART (K140842)Siemens Healthcare Diagnostics, Inc.2014-11-26
ELECSYS FT4 II ASSAY, ELECSYS FT4 II CALSET (K131244)Roche Diagnostics2014-01-27
ADVIA CENTAUR FT4, ADVIA CENTAUR T4 (K132249)Siemens Healthcare Diagnostics, Inc.2013-09-13
LIAISON FT4 LIAISON CONTROL THYROID 1 LIAISON CONTROL THYROID 2 LIAISON CONTROL THYROID 3 (K121951)DiaSorin, Inc.2013-04-04

Recalls involving this device

No recalls on record reference this clearance.